Company / EPS (Basic)
Amneal Pharmaceuticals, Inc. EPS (Basic) History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
-$0.48
FY2025
5-year range
-$2.74 / $0.62
FY2021-FY2025
Trend
+44.2%
vs FY2024
Sector context
#70 of 208
Health Care
What the data says
At $-0.48, Amneal Pharmaceuticals, Inc.'s eps (basic) ranks #70 of 208 in the Health Care sector. EPS (Basic) returned to growth in FY2025 after 2 years of decline, reaching $-0.48.
Based on SEC 10-K filings.
-0.48 in FY2025.
Declined from $0.07 to $-0.48 over the past 2 years.
Health Care sector context is included.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#70 of 208 in Health CareTop 34% of 208This company -$0.48 Sector average -$0.87
▼
+44.9% above sector average
Key checks
Key Insights
- In FY2025, eps (basic) increased 44.2% year-over-year.
- Ranks #70 out of 208 companies in the Health Care sector.
- Peak eps (basic) was recorded in FY2022.
- Lowest eps (basic) in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 1.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.48 | +44.2% |
| FY2024 | -$0.86 | -1328.6% |
| FY2023 | $0.07 | -88.7% |
| FY2022 | $0.62 | +122.6% |
| FY2021 | -$2.74 | -1612.5% |
| FY2020 | -$0.16 | +56.8% |
| FY2019 | -$0.37 | - |
| FY2018 | $0.00 | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026